Albany, NY -- (SBWIRE) -- 07/27/2017 -- Global Obsessive Compulsive Disorder Market: Overview

Obsessive-compulsive disorder (OCD) may be defined as an anxiety disorder that is characterized by unreasonable and uncontrollable thoughts and fears that lead an individual to perform repetitive behaviors. Obsessive-compulsive disorder compels a person to get stuck on a particular thought or fear. For example, a person afraid of contamination may wash his/her hands repetitively in an order to make sure his/her hands are clean. Likewise, a person may check a gas stove multiple times to be sure that it's really turned off. Usually people affected with obsessive-compulsive disorder possess both obsessions as well as compulsions; however, in many cases individuals may have either obsessions or compulsions.

Some common thoughts that usually pop up in mind of people with obsessive-compulsive disorder are fear of being contaminated by germs or dirt, excessive thinking about religious or moral ideas, superstitions, having things orderly or symmetrical, doubts that stove is turned off and thoughts of hurting oneself or others. These thoughts cause people with obsessive-compulsive disorder to perform actions like repeatedly checking of things such as locks and switches; repeatedly reciting certain words with intent to reduce anxiety, ordering or arranging things and accumulating wastes like newspaper, wine bottles or empty food containers. The exact causes of OCD are not known, however, some possible reasons may include differences in brain structure and genetic factors.

Obtain Report Details: http://www.transparencymarketresearch.com/obsessive-compulsive-disorder-therapeutics-market.html

The treatment involves psychotherapy as well as medication. Cognitive behavior therapy (CBT) is a specific type of psychotherapy that has been useful in treating people with OCD. Cognitive behavior therapy (CBT) teaches a person multiple ways of thinking, reacting and handling a particular situation. Most commonly used medications for treating OCD include antidepressants and anti-anxiety medications. A child suffering from PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections) is prescribed antibiotics for treating strep infections and SSRI medicines (citalopram, escitalopram, fluoxetine, sertraline and paroxetine).

Global Obsessive Compulsive Disorder Market: Trends

The market for obsessive-compulsive disorder (OCD) is expected to grow globally under the influence of high prevalence of OCD and life style changes causing changes in thinking processes. According to International OCD Foundation, approximately 2-3 million adults are living with OCD in the United States. The International OCD Foundation also states that nearly 500,000 American children have OCD. A large number of cases of OCD go unreported as many people are not aware that there is any such specific disease. Also, many people hide their illness in order to avoid embarrassment.

Global Obsessive Compulsive Disorder Market: Regional Outlook

Geographically, the market for obsessive-compulsive disorder (OCD) has been segmented into North America, Europe, Asia-Pacific and Rest of the World (RoW). North America was the largest regional market in 2013, followed by Europe, Asia-Pacific and Rest of the World (RoW). One of the major factors responsible for North America's leading position in this particular market is well established health coverage in the region and high level of awareness regarding the illness. In Asia-Pacific and Rest of the World (RoW) regions, the market is expected to grow in coming future owing rise in prevalence of people with OCD and increasing wareness regarding the disease. Japan, China, India, Australia and New Zealand are the most potential markets in the Asia-Pacific region.

Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14720

Global Obsessive Compulsive Disorder Market: Key Players

Some major companies and research institutions that are extensively engaged in the development, manufacturing and marketing of OCD drugs include Abbott Laboratories, Pfizer Ltd., Merck & Co., Sanofi, Novartis AG, University of South Florida, Ortho-McNeil Janssen Scientific Affairs, LLC and Indiana University.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/